From IPCPR: Earlier today, the US Food & Drug Administration (FDA) announced extensions to three advanced notice of proposed rulemaking (ANPRM) dockets currently underway. The extension covers the ANPRMs on nicotine reduction, flavors and premium cigars.
This extension provides additional time for industry to present its case to the administration and submit comments to the FDA. IPCPR, along with other industry associations, members of Congress and industry stakeholders submitted extension requests. Our association applauds the FDA’s decision and attributes it to the continued dialogue IPCPR has forged on Capitol Hill and with the FDA regarding premium cigars and a need to exempt this niche artisanal industry from an ill-suited regulatory framework.
The new ANPRM deadlines are listed below: